|
Volumn 607, Issue 1, 2008, Pages 83-91
|
Analytical artefacts in the speciation of arsenic in clinical samples
|
Author keywords
Acute promyelocytic leukaemia (APL); Analytical losses; Arsenic trioxide; Cancer treatment; Multiple myeloma (MM)
|
Indexed keywords
ARSENIC;
BIOLOGICAL MATERIALS PRESERVATION;
METABOLITES;
NEUTRON ACTIVATION ANALYSIS;
ONCOLOGY;
PATIENT TREATMENT;
ACUTE PROMYELOCYTIC LEUKAEMIA (APL);
ANALYTICAL LOSSES;
ARSENIC TRIOXIDE;
BLOOD FRACTIONS;
FLOW INJECTION;
MULTIPLE MYELOMA (MM);
PRESERVATION AGENTS;
BODY FLUIDS;
ARSENIC TRIOXIDE;
ASCORBIC ACID;
CYSTEINE;
FERRITIN;
GLUTATHIONE;
LIQUID NITROGEN;
MELPHALAN;
METALLOTHIONEIN;
ARTICLE;
BLOOD CELL;
BLOOD SAMPLING;
CANCER THERAPY;
CASE REPORT;
CLINICAL STUDY;
CONCENTRATION (PARAMETERS);
CONTROLLED STUDY;
DRUG BLOOD LEVEL;
DRUG DISTRIBUTION;
HUMAN;
PRECIPITATION;
PRIORITY JOURNAL;
PROMYELOCYTIC LEUKEMIA;
PROTEIN ANALYSIS;
URINALYSIS;
ARSENICALS;
ARTIFACTS;
CHROMATOGRAPHY, HIGH PRESSURE LIQUID;
HUMANS;
LEUKEMIA, PROMYELOCYTIC, ACUTE;
MASS SPECTROMETRY;
MULTIPLE MYELOMA;
OXIDES;
SPECTROMETRY, FLUORESCENCE;
|
EID: 37449018727
PISSN: 00032670
EISSN: None
Source Type: Journal
DOI: 10.1016/j.aca.2007.11.031 Document Type: Article |
Times cited : (65)
|
References (31)
|